دورية أكاديمية

Obesity, Challenges, and Weight-Loss Strategies for Patients With Ventricular Assist Devices.

التفاصيل البيبلوغرافية
العنوان: Obesity, Challenges, and Weight-Loss Strategies for Patients With Ventricular Assist Devices.
المؤلفون: daSilva-deAbreu A; Department of Cardiovascular Medicine, Mayo Clinic, Rochester, Minnesota, USA; Doctoral School, Universidad de Las Palmas de Gran Canaria, Las Palmas de Gran Canaria, Spain. Electronic address: adrian@mayo.edu., Rodgers JE; Division of Pharmacotherapy and Experimental Therapeutics, UNC Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, North Carolina, USA., Seltz J; Frances Stern Nutrition Center, Tufts Medical Center, Boston, Massachusetts, USA., Mandras SA; Transplant Institute, AdventHealth Orlando, Orlando, Florida, USA., Lavie CJ; Department of Cardiovascular Diseases, John Ochsner Heart and Vascular Institute, Ochsner Clinical School-the University of Queensland School of Medicine New Orleans, Louisiana, USA., Loro-Ferrer JF; Doctoral School, Universidad de Las Palmas de Gran Canaria, Las Palmas de Gran Canaria, Spain., Ventura HO; Department of Cardiovascular Diseases, John Ochsner Heart and Vascular Institute, Ochsner Clinical School-the University of Queensland School of Medicine New Orleans, Louisiana, USA., Schauer PR; Metamor Metabolic Institute, Pennington Biomedical Research Center, Baton Rouge, Louisiana, USA., Vest AR; Division of Cardiology, The CardioVascular Center, Tufts Medical Center, Boston, Massachusetts, USA.
المصدر: JACC. Heart failure [JACC Heart Fail] 2024 Jun 03. Date of Electronic Publication: 2024 Jun 03.
Publication Model: Ahead of Print
نوع المنشور: Journal Article; Review
اللغة: English
بيانات الدورية: Publisher: Elsevier Country of Publication: United States NLM ID: 101598241 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2213-1787 (Electronic) Linking ISSN: 22131779 NLM ISO Abbreviation: JACC Heart Fail Subsets: MEDLINE
أسماء مطبوعة: Original Publication: New York, NY : Elsevier, [2013]-
مستخلص: For adults with advanced heart failure, class II/III obesity (body mass index ≥35 kg/m 2 ) represents major challenges, and it is even considered a contraindication for heart transplantation (HT) at many centers. This has led to growing interest in preventing and treating obesity to help patients with advanced heart failure become HT candidates. Among all weight-loss strategies, bariatric surgery (BSx) has the greatest weight loss efficacy and has shown value in enabling select patients with left ventricular assist devices (LVADs) and obesity to lose sufficient weight to access HT. Nevertheless, both BSx and antiobesity medications warrant caution in the LVAD population. In this review, the authors describe and interpret the available published reports on the impact of obesity and weight-loss strategies for patients with LVADs from general and HT candidacy standpoints. The authors also provide an overview of the journey of LVAD recipients who undergo BSx and review major aspects of perioperative protocols.
Competing Interests: Funding Support and Author Disclosures Dr daSilva-deAbreu owns stocks of TransMedics Group, Inc, Annovis Bio Inc, and Altimmune, Inc. Dr Mandras has received consulting fees from and has been on the speakers’ bureaus for Bayer and United Therapeutics. Dr Lavie has received consulting fees from and has served as a speaker for AstraZeneca; and has served on a DSMB for NovoNordisk on their REDEFINE 3 trial with CagriSema. Dr Ventura has received consulting fees from and has served as a speaker for AstraZeneca. Dr Schauer has consultancy agreements with GI Dynamics, Keyron, Persona, Mediflix, Metabolic Health International, LTD, Lilly, Ethicon, Medtronic, and Novo Nordisk; has ownership interest in SE Healthcare LLC, Mediflix, and Metabolic Health International LTD; and has received research funding from Ethicon and Medtronic. All other authors report that they have no relationships relevant to the contents of this paper to disclose.
(Copyright © 2024 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.)
فهرسة مساهمة: Keywords: bariatric surgery; heart failure; heart transplantation; left ventricular assist devices; obesity; weight loss
تواريخ الأحداث: Date Created: 20240621 Latest Revision: 20240621
رمز التحديث: 20240621
DOI: 10.1016/j.jchf.2024.04.006
PMID: 38904644
قاعدة البيانات: MEDLINE
الوصف
تدمد:2213-1787
DOI:10.1016/j.jchf.2024.04.006